New inhaler may ease mouth pain for head and neck cancer patients

This study tests if a drug called Sapylin, given through an inhaler, can prevent or reduce painful mouth sores caused by chemotherapy and radiation for nasopharyngeal cancer. About 180 adults with advanced cancer will be randomly assigned to receive either Sapylin or the standard treatment dexamethasone. The goal is to find a safer, more effective way to manage this common side effect and help patients complete their cancer therapy.